NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
»29/03/2010 [Independent reports]
Asias spectacular rise create serious challenges

Asia spectacular rise—and bright prospects for growth—have created some serious challenges for governments in the region, not least of which are the needs to adapt to changing disease profiles and rapidly ageing populations,” said Mr Charles Goddard, Editorial Director, Asia-Pacific, Economist Intelligence Unit.

 
Asia spectacular rise—and bright prospects for growth—have created some serious challenges for governments in the region, not least of which are the needs to adapt to changing disease profiles and rapidly ageing populations,” said Mr Charles Goddard, Editorial Director, Asia-Pacific, Economist Intelligence Unit. Mr Goddard noted that much of the region is in the midst of an epidemiologic transition, forcing health systems to fight on two fronts. While non-communicable diseases have become the leading cause of death in Asia, infectious diseases remain a significant part of the burden in many countries. Health systems built largely to provide cures or acute episodic care must now find a way to deal with the very different matter of chronic disease management and patient education. Healthcare systems will need to come to grips with rapidly ageing populations. The percentage of citizens over the age of 65 is rising across the region, most notably in Singapore, Taiwan, Hong Kong, and South Korea. This will require some major preparations such as those being introduced in Singapore, which, among other measures, has created a separate healthcare funding scheme for seniors and is making geriatrics a core part of the undergraduate medical training. “Most countries seem headed for a bigger private sector role in healthcare funding and provision. There is no single model in the region exemplifying the right public-private sector balance, but as governments struggle to expand and adapt their healthcare systems, there is a growing reliance on the private sector—either through choice or neglect. Governments in wealthier states such as South Korea and Hong Kong, which cover most of the cost of basic care universally, are now seeking to contain growing outlays. Poorer countries already have a greater private sector role, which is increasing,” added Mr Goddard. He further observed that access gaps are wide and even could grow. A large percentage of healthcare is funded by private — frequently out-of-pocket — payments in the countries under study. This tends to result in disparity in provision. The most striking gaps are where geography and wealth inequality mix, with the countryside often faring very badly. There is a serious risk that the differences in provision for rich and poor will increase as growing patient demand puts greater pressure on health systems and the private sector plays a greater role in the region’s healthcare. Mr Charles Goddard will be presenting key findings from an Economist Intelligence Unit white paper titled “Side effects: Challenges facing healthcare in Asia at the Healthcare in Asia roundtable to be held in Singapore on March 30. The report sets out the challenges faced by 11 countries — China, Hong Kong, India, Indonesia, Malaysia, the Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam — as well as some of the innovative solutions being adopted to cope with them. Mr Arthur Higgins, Chief Executive Officer, Bayer HealthCare, Germany, Professor Phua Kai-Hong, Associate Professor of Health Policy and Management, Lee Kuan Yew School of Public Policy, National University of Singapore; Ms Barbara Archbold, partner, healthcare leader, global business services, ASEAN, Singapore shared their views on the latest developments related to healthcare in Asia. Healthcare ministers, policymakers and practitioners will be sharing their views at the Healthcare in Asia Economist Conferences in Singapore on March 30 and 31, and also to debate and explore Asia\'s healthcare challenges, and the priorities for reform. AstraZeneca, Bayer Schering Pharma and IBM are the lead sponsors of Healthcare in Asia, with Ernst & Young, Glaxo SmithKline, Microsoft, MSD, Pfizer and sanofi-aventis as supporting sponsors. © BioSpectrum Bureau

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.